Insider trades

Badreddin Edris, Director of Edgewise Therapeutics EWTX, has filed 0 purchases and 19 sales on the open market. Over the past 12 months that comes to a net sale of $3.4M. The latest trade was on 06/05.

Badreddin Edris

Director
First filing
23/01/10
Trades
56 trades
Buys / sales
0 / 19
12-month net buying
−$3.4M
Last trade
06/05

Trading activity

Transactions

Trade type
EWTX
Open-market sale10b5-1 plan01/2101/23115,471 sh5 trades$29.44avg.$3,399,466.24−85.4%
Open-market sale10b5-1 plan25/03/0325/03/0520,000 sh4 trades$54.23avg.$1,084,596.92−10.5%
Open-market sale10b5-1 plan25/02/1025/02/1230,000 sh$53.13$1,593,900−13.7%
Open-market sale10b5-1 plan24/12/0324/12/0520,000 sh2 trades$41.96avg.$839,295.64−8.7%
Open-market sale10b5-1 plan24/09/0324/09/0420,000 sh3 trades$40.65avg.$812,933.8−8.0%
Open-market sale10b5-1 plan24/06/0324/06/0520,000 sh4 trades$40.07avg.$801,359.62−7.4%